ipazilide fumarate

Also Known As:

N-(3-diethylaminopropyl)-4,5-diphenyl-1H-pyrazole-1-acetamide(E)-2-butenedioate; Win 54,177-4

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Heart Failure 07/01/1994 - "The hemodynamic actions of the antiarrhythmic agent ipazilide fumarate in patients with congestive heart failure." 07/01/1994 - "Because of the frequent use of antiarrhythmic agents in patients with heart failure, we investigated the hemodynamic effects of oral administration of 400, 200, and 100 mg of ipazilide fumarate in 15 patients with congestive heart failure. "

1.	Oral Administration